Principle Investigators and Coworkers of the Research Unit FOR 2858
A1: TSPO PET labeling in gliomas as a diagnostic marker in the human brain
Prof.?Dr. med. Nathalie Albert
Nuklearmedizinische Klinik und Poliklinik
Klinikum Gro?hadern der?Ludwig-Maximilians-Universit?t München
Nathalie.Albert@med.uni-muenchen.de
Prof. Dr. med. Peter Bartenstein
Nuklearmedizinische Klinik und Poliklinik
Klinikum Gro?hadern der?Ludwig-Maximilians-Universit?t München
Peter.Bartenstein@med.uni-muenchen.de
Prof. Dr. med. J?rg-Christian Tonn
Neurochirurgische Klinik und Poliklinik
Klinikum Gro?hadern der?Ludwig-Maximilians-Universit?t München
Joerg.Christian.Tonn@med.uni-muenchen.de
Dr. med. Adrien Holzgreve
Nuklearmedizinische Klinik und Poliklinik
Klinikum Gro?hadern der?Ludwig-Maximilians-Universit?t München
Dr. rer. nat. Lena Kaiser
Nuklearmedizinische Klinik und Poliklinik
Klinikum Gro?hadern der Ludwig-Maximilians-Universit?t München
Lena.Kaiser@med.uni-muenchen.de
Dr. med. Franziska Vettermann
Nuklearmedizinische Klinik und Poliklinik
Klinikum Gro?hadern der?Ludwig-Maximilians-Universit?t München
Franziska.Vettermann@med.uni-muenchen.de
A2: Histological and molecular characterization of TSPO labeling in human brain tissue
Prof. Dr. med. Markus J. Riemenschneider
Abteilung für Neuropathologie
Universit?tsklinikum Regensburg
Dr. sc. Julia Lorenz
Abteilung für Neuropathologie
Universit?tsklinikum Regensburg
Lorraine Weidner, MSc
Abteilung für Neuropathologie
Universit?tsklinikum Regensburg
A3:?The role of TSPO in T cell immune control of glioblastoma
Prof. Dr. med. Philipp Beckhove
Regensburger Centrum für Interventionelle Immunologie (RCI)
c/o Universit?tsklinikum Regensburg
Prof. Dr. med. Peter Hau
AG?NeuroOnkologie
Klinik und Poliklinik für Neurologie - NeuroOnkologie?
Universit?tsklinikum Regensburg
Dr. rer. nat. Arabel Vollmann-Zwerenz
AG Neuroonkologie
Universit?tsklinikum Regensburg
Ayse Nur Menevse, MSc
Regensburger Centrum für Interventionelle Immunologie (RCI)
c/o Universit?tsklinikum Regensburg
B1:?Nuclear magnetic resonance (NMR) spectroscopy of human TSPO
Prof. Dr. rer. nat. Markus Zweckstetter
Senior Research Group ?Structural Biology in Dementia“
Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), G?ttingen
Gwladys Riviere, MSc
Research Group Protein Structure Detrmination using NMR
MPI for Biophysical Chemistry, G?ttingen
B2:?Architecture and function of the mitochondrial VDAC/TSPO super-complex
Prof. Dr. rer. nat. Christine Ziegler
Department of Structural Biology
Institute of Biochemistry, Genetics, Microbiology
University of?Regensburg
Prof. Dr. rer. nat. Christian Wetzel
Molecular Neurosciences
Department of Psychiatry and Psychotherapy
University of Regensburg
Stefanie Bader, MSc
Molecular Neurosciences
Department of Psychiatry and Psychotherapy
University of Regensburg
Felix Fischer, MSc
Department of Structural Biology
Institute of Biochemistry, Genetics, Microbiology
University of?Regensburg
felix.fischer@biologie.uni-regensburg.de
C1:?Neuroprotective and neuroregenerative effects of new TSPO ligands in the peripheral nervous system
Dr. Michael Schumacher, PhD
Research Unit U1195 Inserm and University Paris Sud and University Paris-Saclay
94276 Kremlin-Bicêtre
Frankreich
C2:?In-depth in vivo analysis of TSPO functions in retinal degeneration
Prof. Dr. rer. nat. Antje Grosche
Ludwig-Maximilians-Universit?t München
Department of Physiological Genomics
BioMedical Center - BMC
Oliver Bludau
Ludwig-Maximilians-Universit?t München
Department of Physiological Genomics
BioMedical Center - BMC
C3:?The role of TSPO on dendritic spine structural plasticity in health and neurodegenerative diseases
Dr. med. Mario Dorostkar
Zentrum für Neuropathologie und Prionforschung (ZNP) &
Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)
Ludwig-Maximilians-Universit?t München
mario.dorostkar@med.uni-muenchen.de
Prof. Dr. med. Jochen Herms
Zentrum für Neuropathologie und Prionforschung (ZNP) &
Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)
Ludwig-Maximilians-Universit?t München
jochen.herms@med.uni-muenchen.de
Katharina Ochs, MSc
Zentrum für Neuropathologie und Prionforschung (ZNP) &
Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)
Ludwig-Maximilians-Universit?t München
katharina.ochs@med.uni-muenchen.de
C4:?Neurobiological analysis of behavioral effects of TSPO ligands in animal models of?stress, anxiety and fear
Prof. Dr. rer. nat. Oliver Bosch
Department of Behavioural and Molecular Neurobiology
University of Regensburg
oliver.bosch@biologie.uni-regensburg.de
Prof. Dr. rer. nat. Inga D. Neumann
Department of Behavioural and Molecular Neurobiology
University of Regensburg
inga.neumann@biologie.uni-regensburg.de
Lilith Fischer, cand. med.
Department of Behavioural and Molecular Neurobiology
University of Regensburg
lilith.fischer@stud.uni-regensburg.de
C5:?Differential effects of TSPO ligands on functional connectivity and metabolism related to fear and anxiety in the human brain
Prof. Dr. rer. nat. Jens Schwarzbach
Biomedical Imaging
Department of Psychiatry and Psychotherapy
University of Regensburg
Prof.?Dr. med. Caroline Nothdurfter
Department of Psychiatry and Psychotherapy
University of Regensburg
Clinic and Policlinic for Psychiatry and Psychotherapy
Bezirksklinikum Regensburg
medbo KU
Prof. Dr. med. Rainer Rupprecht
Department of Psychiatry and Psychotherapy
University of Regensburg
Clinic and Policlinic for Psychiatry and Psychotherapy
Bezirksklinikum Regensburg
medbo KU
Dr. med. Marco Kufner
Department of Psychiatry and Psychotherapy
University of Regensburg
Clinic and Policlinic for Psychiatry and Psychotherapy
Bezirksklinikum Regensburg
medbo KU
Christian Wetzel - 29.04.2025 12:08 
